high yield investments

Shutterstock

It used to be that finding a decent yield in the stock market was easy.

Just seven years ago, all you had to do was buy an ETF in a sector that got income hounds’ hearts racing, like the Utilities Select SPDR ETF (XLU) and lock in an easy 4.48% payout:

The “Good Old Days” Are Over for Utility Fans

But do the same today, and you’ll get just 3.1% for your trouble, no thanks to the merciless rise in stocks (and shriveling of yields) driven by a decade of near-zero interest rates.

And sure, a 3.1% payout may still sound okay. It is, after all, 63% more than you’d get from your average S&P 500 dividend payer.

high yield investments: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha) CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update. Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million. The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62. Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold. Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split. Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period. AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016. Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):

high yield investments: ResMed Inc.(RMD)

Advisors’ Opinion:

  • [By STOCKPICKR]

    Medical equipment maker ResMed (RMD) is another name that’s starting to look “toppy” after a bullish start to the year. RMD has more or less kept pace with the S&P 500 in 2014, climbing just over 11% from January to today — but shares started forming a long-term triple-top over the summer, and that setup is getting close to completion this fall.

    It’s worth noting that long-term price setups come with equally long term trading implications when they trigger.

    The triple-top that RMD is showing is a fairly rare pattern, but the trigger is pretty perfunctory: if shares break down below support at $48, then sellers are in control, and it’s time to unload them. Downside isn’t a foregone conclusion in ResMed, but this setup only gets invalidated if shares can close above their prior highs at $54.

high yield investments: Brown(n)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

high yield investments: Corning Incorporated(GLW)

Advisors’ Opinion:

  • [By Frank DiPietro]

    When Corning Inc. (NYSE:GLW) reported earnings in late January, it committed to continue to reward stockholders handsomely. Its stock price has appreciated nicely over the past 12 months (up roughly 50%) and now it has reiterated its plan to buy back its own shares over the next three years and continue to pay its shareholders a growing dividend. Total cost to the company is projected by management to be at least $12.5 billion through 2019, including annual dividend increases projected to be more than 10%.

  • [By Laurie Kulikowski]

    We rate CORNING INC as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. 

  • [By Laurie Kulikowski]

    GLW’s debt-to-equity ratio is very low at 0.20 and is currently below that of the industry average, implying that there has been very successful management of debt levels. Along with this, the company maintains a quick ratio of 3.30, which clearly demonstrates the ability to cover short-term cash needs.

     

  • [By Steve Symington]

    Corning’s (NYSE:GLW) cutting-edge glass technology can already be found everywhere from smartphones to LCD TVs, advanced optics systems, lab science equipment, and even the ceramic substrates and particulate filters underlying pollution control systems in millions of vehicles today.But Corning is ready to take its show on the road in a much more visible way.

  • [By Peter Graham]

    Back on December 5th of 2013, we added Corning (GLW) to our list around $16 and change. The stock ended up moving to a high of just over $25 per share early last year for roughly a 50% gain. Well, the stock has since come off again trading all the way back down to under $16 per share back in August of last year, before finding its way back up above $18 just yesterday. The context here is two-fold. First, the valuation metrics for GLW are once again suggesting another undervalued opportunity for a Company that is the clear leader in specialty glass and ceramics.

high yield investments: PRA Group, Inc.(PRAA)

Advisors’ Opinion:

  • [By Lee Jackson]

    PRA Group Inc. (NASDAQ: PRAA) has been hit hard recently, and shareholders may be glad to know that a director took advantage of the sell-off and stepped in to buy shares. That board member bought 143,000 shares of the financial and business services company at prices that ranged from $34.40 to $34.89. The total for the buy was set at $5 million. The stock closed Friday at $32.90, in a52-week range of $21.93 to $42.70. The consensus price target is $40.60.

Leave a Reply

Your email address will not be published. Required fields are marked *